Mary Thistle

Mary Thistle joined the Bill & Melinda Gates Medical Research Institute as the Chief of Staff in 2018 and currently serves as a Special Advisor to the organization. Mary is a biopharmaceutical leader with more than 25 years expertise of driving accelerated growth, leading organizations’ strategy, operations, and business development. Before joining the Gates MRI, she was the COO for Dimension Therapeutics, a gene therapy company focused on rare diseases of the liver. Prior to Dimension, Mary was the Senior Vice President of Corporate Development at Cubist Pharmaceuticals, the global leader in anti-infective medicines. Prior to Cubist, Mary held a number of senior executive operating roles across finance, commercial, manufacturing and business development. She holds a Bachelor of Science from the University of Massachusetts. Mary serves on the Board of Directors for Enterome Biosciences, Homology Medicines and Ziopharm Oncology.